Formulation and Characterization of Miconazole Nitrate Emulgel for Topical Delivery.

Abstract

Miconazole nitrate is a widely used imidazole antifungal agent effective against a broad range of fungal pathogens responsible for superficial skin infections. Despite its extensive clinical use, the therapeutic efficacy of miconazole nitrate is often limited due to its poor aqueous solubility, low skin penetration, and reduced bioavailability when formulated in conventional topical dosage forms such as creams and ointments. To overcome these limitations, emulgel has emerged as a promising novel topical drug delivery system, especially suitable for hydrophobic drugs. Emulgel combines the advantages of both emulsion and gel systems, providing enhanced drug solubilization, controlled drug release, improved stability, and better patient compliance. This review article compiles and critically analyzes published literature on the formulation

Keywords

Introduction

Fungal infections of the skin and mucous membranes are among the most prevalent infectious diseases worldwide. Dermatophytosis, candidiasis, and pityriasis versicolor are commonly encountered superficial fungal infections that significantly affect quality of life. Topical antifungal therapy is preferred for superficial infections due to localized action, minimal systemic side effects, and improved patient compliance.

Miconazole nitrate, an imidazole derivative, is widely prescribed for the treatment of various fungal infections. However, its poor aqueous solubility and limited permeability across the stratum corneum result in suboptimal therapeutic outcomes when formulated using conventional dosage forms. Novel drug delivery systems have therefore been explored to enhance the topical bioavailability of such hydrophobic drugs. Among these, emulgel has gained considerable attention due to its ability to incorporate hydrophobic drugs into a patient-friendly semisolid system

3.MICONAZOLE NITRATE: AN OVERVIEW

3.1Chemical Structure and Classification

Miconazole nitrate belongs to the imidazole class of antifungal agents. Chemically, it is 1-[2-[(2,4-dichlorobenzyl) oxy]-2-(2,4-dichlorophenyl) ethyl]-1H-imidazole nitrate.

3.2Mechanism of Action

Miconazole nitrate exerts its antifungal activity by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. This leads to increased membrane permeability, leakage of intracellular contents, and eventual fungal cell death.

3.3Physicochemical Properties

Miconazole nitrate is a crystalline powder, poorly soluble in water but soluble in organic solvents. It is classified as a BCS Class II drug due to its low solubility and high permeability.

3.4Therapeutic Uses

It is used in the treatment of candidiasis, dermatophytosis, tinea infections, and other superficial mycoses.

3.5 Limitations of Conventional Formulations

Conventional creams and ointments often show poor drug release, greasiness, and reduced patient acceptability, necessitating advanced delivery approaches.

4.EMULGEL AS A NOVEL TOPICAL DRUG DELIVERY SYSTEM

Emulgel is a biphasic system where an emulsion (oil-in-water or water-in-oil) is incorporated into a gel base. This system is particularly beneficial for hydrophobic drugs that are difficult to incorporate into aqueous gel systems.

ADVANTAGES OF EMULGEL

• Improved solubility of hydrophobic drugs
• Dual-controlled release mechanism
• Non-greasy and easily spreadable
• Enhanced physical stability
• Improved patient compliance

5.FORMULATION ASPECTS OF MICONAZOLE NITRATE EMULGEL

5.1Selection of Oil Phase

Light liquid paraffin, oleic acid, and castor oil are commonly used oils for solubilizing miconazole nitrate.

5.2Selection of Surfactants and Co-surfactants

Non-ionic surfactants such as Tween 20 and Tween 80 are preferred due to low skin irritation potential. Propylene glycol and PEG 400 are commonly used as co-surfactants.

5.3 Selection of Gelling Agents

Carbopol 940 and Carbopol 981 are widely used due to their excellent gelling properties and skin compatibility.

6.METHODS OF PREPARATION OF EMULGEL

The gel base is prepared by dispersing the gelling agent in purified water and neutralizing with triethanolamine. The emulsion is prepared separately by heating oil and aqueous phases and then mixing them with continuous stirring. The prepared emulsion is incorporated into the gel base in an appropriate ratio to obtain emulgel.

7.CHARACTERIZATION AND EVALUATION PARAMETERS

• Physical appearance
• pH
• Viscosity
• Spreadability
• Extrudability
• Drug content
• In-vitro drug release studies
• Antifungal activity
• Skin irritation studies

8.RECENT ADVANCES AND RESEARCH STUDIES

Various studies have reported that miconazole nitrate emulgels exhibit superior drug release, prolonged antifungal activity, and improved patient compliance compared to conventional creams.

FUTURE PERSPECTIVES

Further research is required for clinical evaluation, stability testing, and large-scale manufacturing of miconazole nitrate emulgel formulations.

CONCLUSION

Miconazole nitrate emulgel is a promising topical drug delivery system that effectively overcomes the limitations of conventional formulations. Enhanced drug release, better antifungal activity, and improved patient acceptability make emulgel a suitable carrier for topical delivery of miconazole nitrate.

ACKNOWLEDGEMENT

Proff.ilsa momin has supported with this review article, shri pandit baburao chaughule College Of Pharmacy bhiwandi ,India.

REFERENCES

1. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20(1):63–67.
2. Kute B, Saudagar R. Emulsified gel: A novel approach for delivery of hydrophobic drugs. J Adv Pharm Educ Res. 2013;3(4):368–376.
3. Roychowdhury S, Singh DS, Gupta R. A review on pharmaceutical gel. Int J Pharm Res Biosci. 2012;1(3):21–36.
4. Basha BN, Prakasam K. Formulation and evaluation of gel containing fluconazole. Int J Drug Dev Res. 2011;3(1):109–118.
5. Naga Sravan Kumar Varma V, et al. Calcipotriol delivery into the skin as emulgel. Saudi Pharm J. 2014;22(6):591–599.
6. Shelke SJ, Shinkar DM, Saudagar RB. Topical gel: A novel approach. Int J Pharm Technol. 2013; 5:2739–2763.
7. Chittodiya P, Tomar RS. Topical gel: A review. Int J Pharm Biol Arch. 2013;4(4):606–613.
8. Gadad AP, Magdum AP, Dandagi PM. Emulgel for topical antifungal delivery. Indian J Health Sci Biomed Res. 2017;10(3):303–310.
9. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133.
10. Singh P, Kalia S, Bala R. Development and characterization of emulgel systems. World J Pharm Res. 2015;4(5):913–918.